™,
`mY
`
`—
`
`WIPO
`WORLD
`INTELLECTUAL PROPERTY
`ORGANIZATION
`
`DOCUMENT MADE AVAILABLE UNDER THE
`PATENT COOPERATION TREATY (PCT)
`International application number:
`PCT/CA2017/050998
`
`International filing date:
`
`24 August 2017 (24.08.2017)
`
`Documenttype:
`
`Documentdetails:
`
`Certified copy of priority document
`
`Country/Office:
`Number:
`Filing date:
`
`US
`62/378,939
`24 August 2016 (24.08.2016)
`
`Date of receipt at the International Bureau:
`
`04 September 2017 (04.09.2017)
`
`Remark: Priority document submitted or transmitted to the International Bureau in compliance with Rule
`17.1(a),(b) or (b-bis)
`
`34, chemin des Colombettes
`1211 Geneva 20, Switzerland
`
`www.wipo.int
`
`Petitioner's Exhibit 1007
`Page | of 66
`
`Petitioner's Exhibit 1007
`Page 1 of 66
`
`

`

`Diaital A
`igital Access
`(DAS)
`
`Servi
`vervice
`
`WIPO
`WORLD
`INTELLECTUAL PROPERTY
`ORGANIZATION
`
`CERTIFICATE OF AVAILABILITY OF A CERTIFIED PATENT DOCUMENT INA
`DIGITAL LIBRARY
`
`The International Bureau certifies that a copy of the patent application indicated
`below has been available to the WIPO Digital Access Service since the date of
`availability indicated, and that the patent application has been available to the
`indicated Office(s) as of the date specified following the relevant Office code:
`
`Documentdetails:
`
`Country/Office: US
`
`Filing date: 24 Aug 2016 (24.08.2016)
`
`Application number: 62378939
`
`Date of availability of document:
`
`07 Sep 2016 (07.09.2016)
`
`The following Offices can retrieve this document by using the access code:
`JP, US, SE, NZ, KR, GB, AU, ES, IB, EE, CN, MA, FI
`
`Date of issue of this certificate:
`
`04 Sep 2017 (04.09.2017)
`
`34, chemin des Colombettes
`1211 Geneva 20, Switzerland
`
`Petitioner's Exhibit 1007
`Page 2 of 66
`
`Petitioner's Exhibit 1007
`Page 2 of 66
`
`

`

`
`
`
`Ss :
`be
`
`NS s
`
`
`USTED STATES DEPARTMENTOF COMMERCE
`
`United States Patent mad Prademark Office
`
`
`
`
`
`SsRw
`
`
`
`
`
`
`
`
`
`
`
`LATA
`ES
`
`X
`
`EAS + WS
`S
`
`WS| :
`
`RS
`winx,
`as
`S
`AA
`
`
`
`
`
`
`
`INaa ye WWNE TVRGOS
`
`
`
`
`VC NS VN SOE LN WSXv5 Oss Vs V © SGAS Ye\ OS NS
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`September 04, 2017
`
`
`
`
` THIS IS TO CERTIFY THAT ANNEXED HERETOIS A TRUE COPY FROM
`
`
`
`THE RECORDSOF THE UNITED STATES PATENT AND TRADEMARK
`men
`
`
`%.es
`
`OFFICE OF THOSE PAPERS OF THE BELOW IDENTIFIED PATENT
`
`
`ih
`fs,
`
`APPLICATION THAT MET THE REQUIREMENTSTO BE GRANTED A
`Mts.
` betta
`+ies
`FILING DATE UNDER35 USC 111.
`
` APPLICATION NUMBER: 62/378,939
`
`FILING DATE: August 24, 2016
`
`THE COUNTRY CODE AND NUMBEROF YOUR PRIORITY
`APPLICATION, TO BE USED FOR FILING ABROAD UNDER THE PARIS
`CONVENTION,IS US62/378, 939
`
`ay
`
`fe
`
`
`
`
`
`
`fidetariete
`ppapyeunig Zs
`
`
`
`
`
`
`
`
`
`
`
`Certified by
`
`Under Seeretary of Commeree
`for heteHectual Property
`and Director of the United States
`Patent and Frademark Office
`
`ReSAS,
`
`
`
`
`
`
`Petitioner's Exhibit 1007
`Page 3 of 66
`
`Petitioner's Exhibit 1007
`Page 3 of 66
`
`

`

`Doc Code: TR.PROV
`Document Description: Provisional Cover Sheet (SB16)
`
`PTO/SB/16 (11-08)
`Approvedfor use through 05/31/2015. OMB 0651-0032
`U.S. Patent and Trademark Office: U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number
`
`Provisional Application for Patent Cover Sheet
`This is a requestforfiling a PROVISIONAL APPLICATION FOR PATENTunder 37 CFR 1.53(c)
`
`Inventor(s)
`
`
`Inventor 1
`Remove
`
`
`
`
`
`
`Country j
`State
`City
`Family Name
`Middle Name
`Given Name
`
`
`eeeBeee
`
`
`
`Inventor 2
`
`
`Add
`All Inventors Must Be Listed — Additional Inventor Information blocks may be
`generated within this form by selecting the Add button.
`
`Given Name
`
`Middle Name
`
`
`Family Name
`
`City
`
`State
`
`Country j
`
`
`
`
`
`
`Title of Invention
`
`ULTISPECTRAL MOBILE TISSUE ASSESSMENT
`
`
`Attorney Docket Number (if applicable)
`|
`p5643-P51 502US00
`
`Correspondence Address
`
`Direct all correspondenceto (select one):
`
`
`
`
`
`(@) The address corresponding to Customer Number
`©) Firm or Individual Name
`
`
`Customer Number
`
`
`
`
`
`
`
`
`
`The invention was made by an agency of the United States Governmentor under a contract with an agency of the United
`States Government.
`
`
`
`e No.
`
`Yes, the invention was made by an agencyof the United States Government. The U.S. Government agency name is:
`
`Yes, the invention was under a contract with an agency of the United States Government. The nameof the U.S.
`Government agency and Government contract number are:
`
`EFS - Web 1.0.1
`
`Petitioner's Exhibit 1007
`Page 4 of 66
`
`Petitioner's Exhibit 1007
`Page 4 of 66
`
`

`

`Doc Code: TR.-PROV
`Document Description: Provisional Cover Sheet (SB16)
`
`PTO/SB/16 (11-08)
`Approvedfor use through 05/31/2015. OMB 0651-0032
`U.S. Patent and Trademark Office: U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number
`
`Entity Status
`Applicant asserts small entity status under 37 CFR 1.27 or applicant certifies micro entity status under 37 CFR 1.29
`
`©) Applicant certifies micro entity status under 37 CFR 1.29. Applicant must attach form PTO/SB/15Aor B or equivalent.
`
`@) Applicant asserts small entity status under 37 CFR 1.27
`
`
`
`
`
`
`Warning
`
`Petitioner/applicant is cautioned to avoid submitting personal information in documentsfiled in a patent application that may
`contribute to identity theft. Personal information such as social security numbers, bank account numbers, or credit card
`numbers (other than a check or credit card authorization form PTO-2038 submitted for payment purposes) is never required
`by the USPTOto support a petition or an application.
`If this type of personal information is included in documents submitted
`to the USPTO, petitioners/applicants should consider redacting such personal information from the documents before
`submitting them to USPTO. Petitioner/applicant is advised that the record of a patent application is available to the public
`after publication of the application (unless a non-publication request in compliance with 37 CFR 1.213(a) is made in the
`application) or issuance of a patent. Furthermore, the record from an abandoned application may also be available to the
`public if the application is referenced in a published application or an issued patent (see 37 CFR1.14}. Checks and credit
`card authorization forms PTO-2038 submitted for payment purposes are not retained in the application file and therefore are
`not publicly available.
`
`Signature
`
`Please see 37 CFR 1.4(d) for the form of the signature.
`
`FirstName
`
`LastName P|SmeeNumber 55091
`
`(lf appropriate)
`
`This collection of information is required by 37 CFR 1.51. The information is required to obtain or retain a benefit by the public whichis to
`file (and by the USPTO©to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.11 and 1.14. This collection
`is estimated to take 8 hours to complete, including gathering, preparing, and submitting the completed application form to the USPTO.
`Time will vary depending upon the individual case. Any comments on the amountof time you require to complete this form and/or
`suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and Trademark Office, U.S. Department
`of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED FORMSTO THIS ADDRESS. This
`form can only be used when in conjunction with EFS-Web. If this form is mailed to the USPTO,it may cause delays in handling
`the provisional application.
`
`EFS - Web 1.0.1
`
`Petitioner's Exhibit 1007
`Page 5 of 66
`
`Petitioner's Exhibit 1007
`Page 5 of 66
`
`

`

`Privacy Act Statement
`
`The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection with your submission of
`the attached form related to a patent application or paten. Accordingly, pursuant to the requirements of the Act, please be
`advised that: (1) the general authority for the collection of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the
`information solicited is voluntary; and (3) the principal purpose for which the information is used by the U.S. Patent and
`Trademark Office is to process and/or examine your submission related to a patent application or patent.
`If you do not
`furnish the requested information, the U.S. Patent and Trademark Office may not be able to process and/or examine your
`submission, which may result in termination of proceedings or abandonmentof the application or expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`
`1.
`
`The information on this form will be treated confidentially to the extent allowed under the Freedom of Information
`Act (5 U.S.C. 552) and the Privacy Act (5 U.S.C 552a). Records from this system of records may be disclosed to the
`Departmentof Justice to determine whether disclosure of these records is required by the Freedom of Information
`Act.
`
`A record from this system of records may be disclosed, as a routine use, in the course of presenting evidence to
`a court, magistrate, or administrative tribunal, including disclosures to opposing counsel in the course of settlement
`negotiations.
`A recordin this system of records may be disclosed, as a routine use, to a Member of Congress submitting a
`request involving an individual, to whom the record pertains, when the individual has requested assistance from the
`Member with respect to the subject matter of the record.
`A record in this system of records may be disclosed, as a routine use, to a contractor of the Agency having need
`for the information in order to perform a contract. Recipients of information shall be required to comply with the
`requirements of the Privacy Act of 1974, as amended, pursuant to 5 U.S.C. 552a(m).
`A record related to an International Application filed under the Patent Cooperation Treaty in this system of
`records maybe disclosed, as a routine use, to the International Bureau of the World Intellectual Property
`Organization, pursuant to the Patent Cooperation Treaty.
`A recordin this system of records may be disclosed, as a routine use, t o a n other federal agency for purposes
`of National Security review (35 U.S.C. 181) and for review pursuant to the Atomic Energy Act (42 U.S.C. 218(c)).
`A record from this system of records may be disclosed, as a routine use, to the Administrator, General Services,
`or his/her designee, during an inspection of records conducted by GSAaspart of that agency’s responsibility to
`recommend improvements in records managementpractices and programs, under authority of 44 U.S.C. 2904 and
`2906. Such disclosure shall be made in accordance with the GSA regulations governing inspection of records for this
`purpose, and any other relevant(i.e., GSA or Commerce) directive. Such disclosure shall not be used to make
`determinations aboutindividuals.
`A record from this system of records may be disclosed, as a routine use, to the public after either publication of
`the application pursuant to 35 U.S.C. 122(b) or issuance of a patent pursuant to 35 U.S.C. 151. Further, a record
`may be disclosed, subject to the limitations of 37 CFR 1.14, as a routine use, to the public if the record wasfiled in an
`application which became abandonedor in which the proceedings were terminated and which application is
`referenced by either a published application, an application open to public inspection or an
`issued patent.
`A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local law
`enforcement agency,if the USPTO becomes awareof a violation or potential viclation of law or regulation.
`
`Petitioner's Exhibit 1007
`Page 6 of 66
`
`Petitioner's Exhibit 1007
`Page 6 of 66
`
`

`

`PTO/AIA/14 (11-15)
`Approved for use through 04/30/2017. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Underthe Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unlessit contains a valid OMB control number.
`
`document may be printed and included in a paperfiled application.
`
`Application Data Sheet 37 CFR 1.76
`
`—
`
`Title of Invention|MULTISPECTRAL MOBILE TISSUE ASSESSMENT
`
`The application data sheetis part of the provisional or nonprovisional application for which it is being submitted. The following form contains the
`bibliographic data arranged in a format specified by the United States Patent and Trademark Office as outlined in 37 CFR 1.76.
`This document may be completed electronically and submitted to the Office in electronic format using the Electronic Filing System (EFS) or the
`
`Secrecy Order 37 CFR 5.2:
`
`Oo Portions orall of the application associated with this Application Data Sheet mayfall under a Secrecy Order pursuant to
`
`37 CFR 5.2 (Paperfilers only. Applications that fall under Secrecy Order may notbefiled electronically.)
`
`Inventor Information:
`
`Remove
`
`generated within this form by selecting the Add button.
`
`{1
`
`Inventor
`Legal Name
`
`[Pref]GivenName=MiddleName===FamllyName(|‘Sufi
`PryKerenMichieBross
`Residence Information (Select One) Active US Military Service US Residency e@ Non US Residency
`
`
`
`
`Mailing Addressof Inventor:
`Address 1
`i 7A Boulton Avenue
`Address 2
`
`
`ity—s|| oronto State/Province | en
`
`Postal Code|[mam 24
`
`Inventor
`Legal Name
`
`[Prefix]GivenName=|MiddleName==FamilyName=|Sufi
`TEBecfeetTT
`Residence Information (Select One)
`US Residency
`(@) Non US Residency
`Active US Military Service
`
`||c
`
`
`
`Mailing Addressof Inventor:
`rAddresst[piessmatet
`Address?[abe
`rciy[feos SCCSCSCSCSC*dSSt ProvinceSSCSC~*
`[PostalGode[pee[County[fASSCS
`All
`Inventors Must Be Listed - Additional
`Inventor Information blocks may be
`
`CorrespondenceInformation:
`EFS Web 2.2.12
`
`Petitioner's Exhibit 1007
`Page 7 of 66
`
`Petitioner's Exhibit 1007
`Page 7 of 66
`
`

`

`PTO/AIA/14 (11-15)
`Approved for use through 04/30/2017. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unlessit contains a valid OMB control number.
`
`og Attorney Docket Number|25643-P51502US00
`
`Application Data Sheet 37 CFR 1.76
`—
`
`Title of Invention|MULTISPECTRAL MOBILE TISSUE ASSESSMENT
`
`Enter either Customer Numberor complete the CorrespondenceInformation section below.
`For further information see 37 CFR 1.33(a).
`
`|] An Addressis being provided for the correspondenceInformation of this application.
`
`Email Address
`
`| orsi@bereskinparr.com
`
`
`
`Application Information:
`
`
`provided in the appropriate section(s) below (i.e., "Domestic Benefit/National Stage Information” and “Foreign Priority Information”).
`
`
`
`
`eeNumberofDrawingSheets(ifany) yo Suggested FigureforPublication(ifany) Bo
`
`Filing By Reference:
`
`Only complete this section whenfiling an application by reference under 35 U.S.C. 111(c) and 37 CFR 1.57{a). Do not complete this sectionif
`application papers including a specification and any drawings are being filed. Any domestic benefit or foreign priority information must be
`
`For the purposesof a filing date under 37 CFR 1.53(b), the description and any drawings of the present application are replaced by this
`reference to the previously filed application, subject to conditions and requirements of 37 CFR 1.57(a).
`i
`
`Application numberof the previously
`filed application
`
`Filing date (YYYY-MM-DD)
`
`Intellectual Property Authority or Country
`
`
`
`ee||
`
`Publication Information:
`
`
`[_] Request Early Publication (Fee required at time of Request 37 CFR 1.219)
`Req uest Not to Publish. | hereby request that the attached application not be published under
`35 ULS.C. 122(b) and certify that the invention disclosed in the attached application has not and will not be the
`Cl
`subject of an application filed in another country, or under a multilateral international agreement, that requires
`publication at eighteen monthsafterfiling.
`
`Representative Information:
`
`Representative information should be provided for all practitioners having a power of attorney in the application. Providing
`this information in the Application Data Sheet does not constitute a powerof attorney in the application (see 37 CFR 1.32).
`Either enter Customer Number or complete the Representative Name section below.
`If both sections are completed the customer
`Numberwill be used for the Representative Information during processing.
`
`
`
`Please Select One:
`
`e@ Customer Number
`
`US Patent Practitioner
`
`©) Limited Recognition (37 CFR 11.9)
`
`EFS Web 2.2.12
`
`Petitioner's Exhibit 1007
`Page 8 of 66
`
`Petitioner's Exhibit 1007
`Page 8 of 66
`
`

`

`PTO/AIA/14 (11-15)
`Approved for use through 04/30/2017. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unlessit contains a valid OMB control number.
`
`og Attorney Docket Number|25643-P51502US00
`
`Application Data Sheet 37 CFR 1.76
`
`— Title of Invention|MULTISPECTRAL MOBILE TISSUE ASSESSMENT
`
`Domestic Benefit/National Stage Information:
`
`This section allows for the applicant to either claim benefit under 35 U.S.C. 119¢e), 120, 121, 365(c), or 386(c} or indicate
`National Stage entry from a PCT application. Providing benefit claim information in the Application Data Sheet constitutes
`the specific reference required by 35 U.S.C. 119{e) or 120, and 37 CFR 1.78.
`Whenreferring to the current application, please leave the “Application Number”field blank.
`
`Prior Application Status
`
`Application Number
`
`Continuity Type
`
`Prior Application Number
`
`Filing or 371(c) Date
`(YYYY-MM-DD)
`
`Additional Domestic Benefit/National Stage Data may be generated within this form
`by selecting the Add button.
`
`Foreign Priority Information:
`
`This section allows for the applicant to claim priority to a foreign application. Providing this information in the application data sheet
`constitutes the claim for priority as required by 35 U.S.C. 119(b) and 37 CFR 1.55. Whenpriority is claimed to a foreign application
`that is eligible for retrieval under the priority document exchange program (PDX)! the information will be used by the Office to
`automatically attempt retrieval pursuant to 37 CFR 1.55(i)(1) and (2). Under the PDX program, applicant bears the ultimate
`responsibility for ensuring that a copy of the foreign application is received by the Office from the participating foreign intellectual
`
`
`
`
`property office, or a certified copy of the foreign priority applicationis filed, within the time period specified in 37 CFR 1.55({g)(1).
`
`Remove
`Access Code! (if applicable)
`
`Application Number
`
`I
`
`Additional Foreign Priority Data may be generated within this form by selecting the
`Age
`Add button.
`
`
`Statement under 37 CFR 1.55 or 1.78 for AIA (First Inventor to File) Transition
`Applications
`
`This application (1) claims priority to or the benefit of an application filed before March 16, 2013 and (2) also
`contains, or contained at any time, a claim to a claimed invention that has an effectivefiling date on or after March
`[] 16, 2013.
`NOTE: By providing this statement under 37 CFR 1.55 or 1.78, this application, with a filing date on or after March
`16, 2013, will be examined underthefirst inventorto file provisions of the AIA.
`
`EFS Web 2.2.12
`
`Petitioner's Exhibit 1007
`Page 9 of 66
`
`Petitioner's Exhibit 1007
`Page 9 of 66
`
`

`

`PTO/AIA/14 (11-15)
`Approved for use through 04/30/2017. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unlessit contains a valid OMB control number.
`
`og Attorney Docket Number|25643-P51502US00
`
`Application Data Sheet 37 CFR 1.76
`
`— Title of Invention|MULTISPECTRAL MOBILE TISSUE ASSESSMENT
`
`Authorization or Opt-Out of Authorization to Permit Access:
`
`
`Whenthis Application Data Sheet is properly signed and filed with the application, applicant has provided written
`authority to permit a participating foreign intellectual property (IP) office access to the instant application-as-filed (see
`paragraph A in subsection 1 below) and the European Patent Office (EPO) access to any search results from the instant
`application (see paragraphBin subsection 1 below).
`
`Should applicant choose not to provide an authorization identified in subsection 1 below, applicant must opt-out of the
`authorization by checking the corresponding box A or B or both in subsection 2 below.
`
`
`
`NOTE: This section of the Application Data Sheet is ONLY reviewed and processed with the INITIALfiling of an
`application. After the initial filing of an application, an Application Data Sheet cannot be used to provide or rescind
`authorization for access by a foreign IP office(s). Instead, Form PTO/SB/39 or PTO/SB/69 must be used as appropriate.
`
`1. Authorization to Permit Access by a Foreign Intellectual Property Office(s)
`
`
`A. Priority Document Exchange (PDX)- Unless box A in subsection 2 (opt-out of authorization) is checked, the
`undersigned hereby grants the USPTO authority to provide the European Patent Office (EPO), the Japan Patent Office
`JPO), the Korean Intellectual Property Office (KIPO), the State Intellectual Property Office of the People’s Republic of
`China (SIPO), the World Intellectual Property Organization (WIPO), and any other foreign intellectual property office
`participating with the USPTOin a bilateral or multilateral priority document exchange agreementin which a foreign
`application claiming priority to the instant patent application is filed, access to: (1) the instant patent application-as-filed
`andits related bibliographic data, (2) any foreign or domestic application to which priority or benefit is claimed by the
`instant application andits related bibliographic data, and (3) the date offiling of this Authorization. See 37 CFR 1.14(h)
`(1).
`
`
`B. Search Results from U.S. Application to EPO - Unless box B in subsection 2 (opt-out of authorization) is checked,
`the undersigned hereby grants the USPTO authority to provide the EPO accessto the bibliographic data and search
`results from the instant patent application when a European patent application claiming priority to the instant patent
`application is filed. See 37 CFR 1.14(h}(2).
`
`the instant application.
`
`The applicant is reminded that the EPO’s Rule 141(1) EPC (European Patent Convention} requires applicants to submit a
`copy of search results from the instant application without delay in a European patent application that claims priority to
`
`2. Opt-Out of Authorizations to Permit Access by a Foreign Intellectual Property Office(s)
`
`[|
`
`A. Applicant DOES NOT authorize the USPTOto permit a participating foreign IP office access to the instant
`application-as-filed.
`If this box is checked, the USPTOwill not be providing a participating foreign IP office with
`any documents and information identified in subsection 1A above.
`
`[|
`
`B. Applicant DOES NOTauthorize the USPTOto transmit to the EPO any search results from the instant patent
`application. If this box is checked, the USPTOwill not be providing the EPO with search results from the instant
`application.
`NOTE: Once the application has published or is otherwise publicly available, the USPTO may provide accessto the
`application in accordance with 37 CFR 1.14.
`
`
`EFS Web 2.2.12
`
`Petitioner's Exhibit 1007
`Page 10 of 66
`
`Petitioner's Exhibit 1007
`Page 10 of 66
`
`

`

`PTO/AIA/14 (11-15)
`Approved for use through 04/30/2017. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unlessit contains a valid OMB control number.
`
`og Attorney Docket Number|25643-P51502US00
`
`Application Data Sheet 37 CFR 1.76
`
`— Title of Invention|MULTISPECTRAL MOBILE TISSUE ASSESSMENT
`
`Applicant Information:
`
`
`Providing assignment information in this section does not substitute for compliance with any requirementof part 3 of Title 37 of CFR
`to have an assignment recorded by the Office.
`
`
`#1
`Applicant
`lf the applicantis the inventor (or the remaining joint inventor or inventors under 37 CFR 1.45), this section should not be completed.
`The information to be provided in this section is the name and addressof the legal representative whois the applicant under 37 CFR
`1.43; or the name and addressof the assignee, person to whom the inventoris under an obligation to assign the invention, or person
`who otherwise showssufficient proprietary interest in the matter who is the applicant under 37 CFR 1.46. If the applicant is an
`applicant under 37 CFR 1.46 (assignee, person to whom the inventor is obligated to assign, or person who otherwise showssufficient
`proprietary interest) together with one or morejoint inventors, then the joint inventor or inventors who are also the applicant should be
`identified in this section.
`
`Legal Representative under 35 U.S.C. 117
`
`Joint Inventor
`
`Person to whom theinventeris obligated to assign.
`
`Person who showssufficient proprietary interest
`
`If applicant is the legal representative, indicate the authority to file the patent application, the inventoris:
`
`
`
`
`
`
`Nameof the Deceased or Legally Incapacitated Inventor:Po
`If the Applicant is an Organization check here.
`[]
`
`
`Prefix = MiddleName
`Mailing Address |— ForApplicant:
`
`Addesst[OOOO
`fadcess?«||CS
`etyIPids tteProvingeTS
`
`FamilyName
`
`Add
`Additional Applicant Data may be generated within this form by selecting the Add button.
`
`
`AssigneeInformation including Non-Applicant Assignee Information:
`
`
`Providing assignment information in this section does not substitute for compliance with any requirementofpart 3 ofTitle
`37 of CFR to have an assignment recorded by the Office.
`
`
`EFS Web 2.2.12
`
`Petitioner's Exhibit 1007
`Page 11 of 66
`
`Petitioner's Exhibit 1007
`Page 11 of 66
`
`

`

`selecting the Add button.
`
`Additional Assignee or Non-Applicant Assignee Data may be generated within this form by
`
`Signature:
`NOTE: This Application Data Sheet must be signed in accordance with 37 CFR 1.33(b). However,if this Application
`Data Sheet is submitted with the INITIALfiling of the application and either box A or B is not checkedin
`subsection 2 of the “Authorization or Opt-Out of Authorization to Permit Access” section, then this form must
`also be signed in accordance with 37 CFR 1.14(c).
`This Application Data Sheet must be signed by a patent practitioner if one or more of the applicants is a juristic
`entity (e.g., corporation or association). If the applicant is two or more joint inventors, this form must be signed by a
`patent practitioner, all joint inventors who are the applicant, or one or more joint inventor-applicants who have been given
`powerof attorney (e.g., see USPTO Form PTO/AIA/81) on behalf ofall joint inventor-applicants.
`See 37 CFR 1.4(d} for the manner of making signatures and certifications.
`
`ony Orsi/
`
`Date (YYYY-MM-DD))
`
`(2016-08-24
`
`Additional Signature may be generated within this form by selecting the Add button.
`
`EFS Web 2.2.12
`
`Petitioner's Exhibit 1007
`Page 12 of 66
`
`PTO/AIA/14 (11-15)
`Approved for use through 04/30/2017. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unlessit contains a valid OMB control number.
`
`og Attorney Docket Number|25643-P51502US00
`
`Application Data Sheet 37 CFR 1.76
`—
`
`Title of Invention|MULTISPECTRAL MOBILE TISSUE ASSESSMENT
`
`Assignee
`
`,
`
`Complete this section if assignee information, including non-applicant assignee information, is desired to be included on the patent
`application publication. An assignee-applicant identified in the "Applicant Information” section will appear on the patent application
`publication as an applicant. For an assignee-applicant, complete this section only if identification as an assigneeis also desired on the
`patent application publication.
`Remove
`
`If the Assignee or Non-Applicant Assignee is an Organization check here
`
`[|
`
`Mailing Address Information For Assignee including Non-Applicant Assignee:
`
`Address 1
`
`reyid Sirovince[SSSCSC~*S
`
`a E
`
`mail Address
`
`Petitioner's Exhibit 1007
`Page 12 of 66
`
`

`

`PTO/AIA/14 (11-15)
`Approved for use through 04/30/2017. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unlessit contains a valid OMB control number.
`
`og Attorney Docket Number|25643-P51502US00
`
`Application Data Sheet 37 CFR 1.76
`
`— Title of Invention|MULTISPECTRAL MOBILE TISSUE ASSESSMENT
`
`This collection of information is required by 37 CFR 1.76. The information is required to obtain or retain a benefit by the public which
`is to file (and by the USPTOto process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.14. This
`collection is estimated to take 23 minutes to complete, including gathering, preparing, and submitting the completed application data
`sheet form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount of time you require to
`complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and
`Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR
`COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissionerfor Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`
`EFS Web 2.2.12
`
`Petitioner's Exhibit 1007
`Page 13 of 66
`
`Petitioner's Exhibit 1007
`Page 13 of 66
`
`

`

`Privacy Act Statement
`
`The information provided by youin this form will be subject to the following routine uses:
`
`1
`
`The information on this form will be treated confidentially to the extent allowed under the Freedom of Information Act (5 U.S.C. 552) and the Privacy
`Act (5 U.S.C. 552a). Records from this system of records may be disclosed to the Departmentof Justice to determine whether the Freedom of
`Information Act requires disclosure of these records.
`
`Arecord from this system of records may be disclosed, as a routine use, in the course of presenting evidence to a court, magistrate, or administrative
`tribunal, including disclosures te opposing counsel in the course of settlement negotiations.
`
`Arecordin this system of records may be disclosed, as a routine use, to a Member of Congress submitting a request involving an individual, to whom
`the record pertains, when the individual has requested assistance from the Memberwith respect to the subject matter of the record.
`
`Arecordin this system of records maybe disclosed, as a routine use, to a contractor of the Agency having need for the information in order to perform
`acontract. Recipients of information shall be required to comply with the requirements of the Privacy Act of 1974, as amended, pursuantto 5 U.S.C.
`552a(m).
`
`A record related to an International Application filed under the Patent Cooperation Treaty in this system of records may be disclosed, as a routine use,
`to the International Bureau of the WorldIntellectual Property Organization, pursuant to the Patent CooperationTreaty.
`
`A recordin this system of records may be disclosed, as a routine use, to another federal agency for purposes of National Security review (35 U.S.C. 181)
`and for review pursuant to the Atomic Energy Act (42 U.S.C. 218{c)).
`
`A record from this system of records may be disclosed, as a routine use, to the Administrator, General Services, or his/her designee, during an
`inspection of records conducted by GSA as part of that agency's responsibility to recommend improvements in records managementpractices and
`programs, under authority of 44 U.S.C. 2904 and 2906. Such disclosure shall be madein accordance with the GSA regulations governing inspection of
`recordsfor this purpose, and any otherrelevant(i.e., GSA or Commerce)directive. Such disclosure shall not be used to make determinations about
`individuals.
`
`A record from this system of records may be disclosed, as a routine use, to the public after either publication of the application pursuantto 35 U.S.C.
`122(b) or issuance of a patent pursuant to 35 U.S.C. 151. Further, a record may be disclosed, subject to the limitations of 37 CFR 1.14, as a routine use,
`to the public if the record wasfiled in an application which became abandonedorin which the proceedings were terminated and which applicationis
`referenced by either a published application, an application open to public inspections or an issued patent.
`
`A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local law enforcement agency,if the USPTO